Lori Chmura

Healthcare Businesswomens Association operates women healthcare associations. The company was founded by Diane Anderson, Peg Dougherty, Millicent Gryczka, Sheila Sinkking and Ruth Smith in 1977 and is headquartered in Fairfield, NJ.

Dune Medical Devices Ltd. engages in the development of real-time cancer detection tools. Its products are MarginProbe and Smart Biopsy System. The company was founded by Dan Hashimshony in 2002 and is headquartered in Caesarea, Israel.

Opsens, Inc. engages in the development, manufacture, supply, and installation of fiber optic systems for measuring pressure and temperature. It operates through the Medical and Industrial business segments. The Medical segment focuses on the physiological measurement in interventional cardiology. The Industrial segment develops, manufactures, and installs fiber optic sensing solutions for critical applications such as the monitoring of oil wells and demanding industrial applications. The company was founded in 2003 and is headquartered in Quebec, Canada.

Women's Executive Network provides professional and executive women's for mentoring and events services. The company was founded in 1997 and is headquartered in Toronto, Canada.

SoundBite Medical Solutions Inc. offers medical devices. It develops and commercializes proprietary shockwave device and generator technology. The company was founded by Steve Arless, Martin Brouillette, Louis-Philippe Riel and Steven Dion and is headquartered in Montreal, Canada.

Dune Medical Devices, Inc. engages in the development, manufacture, and commercialization of medical devices for cancer surgery providing real-time tissue characterization systems. It focuses guiding on surgical and diagnostic decisions. The company was founded by Dan Hashimshony in 2002 and is headquartered in Alpharetta, GA.

The American company is focused on developing the Carlen technology, a transcatheter technology for the treatment of mitral regurgitation. The technology preserves the physiological valve geometry while restoring its function, eliminates the risk of stenosis, and offers the benefit of preserving a full range of transcatheter and surgical treatments as future options. Nyra Medical is also developing a novel transcatheter mitral and tricuspid valve repair technology called the Cardiac Leaflet Enhancer (Carlen), which enables repair of leaky heart valves without the need for open heart surgery. Lori B. Chmura has been the CEO of the company since 2023.